Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Pardes Biosciences, Inc. (PRDS) Investigation

Published July 26, 2023

NEW YORK, NY / ACCESSWIRE / July 26, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FS Development Corp. II, which merged with Pardes Biosciences, Inc. ("Pardes" or "the Company") (NASDAQ:PRDS) on December 27, 2021. Such investors who continue to holdto the present are encouraged to obtain additional information and assist the investigation by visiting the firm's site:

Bronstein, Gewirtz and Grossman, LLC, Wednesday, July 26, 2023, Press release picture

The investigation concerns whether FS Development Corp. II failed to provide relevant information to its shareholders before the merger.

If you are aware of any facts relating to this investigation or hold Pardes shares, you can assist this investigation by visiting the firm's site: You can also contact Peretz Bronstein or his Law Clerk and Clients Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.


Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 |

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View source version on


News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive newswire available today.